Early-onset Dementia
Gene: SQSTM1ClinGen had downgraded in 2022 to moderate gene-disease association for the lumped disease entity.
Reviewed the literature. Gene is not associated with significant pLOF and missense constraint in gnomAD. Variants reported as associated with disease are relatively common in the population. Some individuals with well-reported variants present with Paget's disease, some with ALS/FTD, some with both. Unclear what other factors are contributing to help delineate genotype-phenotype correlation.
Overall, previously reported LP/P variants in this gene may be risk-alleles for the lumped disease entitity associated with this gene (Paget's Disease, ALS/FTD), but these are not well-defined risk alleles.
Have downgraded to Amber for the AD association.Created: 20 Nov 2025, 10:52 a.m. | Last Modified: 20 Nov 2025, 10:52 a.m.
Panel Version: 1.50
Although ClinGen has downgraded to moderate in the past they cite that there is no convincing contradictory evidence for this gene-disease association. Missense variants in SQSTM1 are a common cause of disease (PMIDs: 31859009, 23942205) with functional studies showing loss of function however dominant negative has not been excluded (PMIDs: 27554286, 31362587, 28490746). Although non-segregation of variant and disease has been suggested in PMID: 31859009.
Presence of multiple unrelated individuals and functional studies with no conflicting evidence, Clingen moderate not limited. Proposing upgrade to green for this gene for FTD/ALSCreated: 23 Jun 2025, 4:10 p.m. | Last Modified: 23 Jun 2025, 4:10 p.m.
Panel Version: 1.41
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (MIM#616437)
Publications
ClinGen ALS GCEP classification on 13/12/2022 was downgraded to moderate for FTD and/or ALS due to lack of evidence supportive of a gene-disease association. Distinct mechanism of disease is unknown and current evidence is conflicting.
Multiple individuals with FTD and/or ALS have been reported with mutations in SQSTM1.Created: 16 Aug 2023, 11:22 a.m. | Last Modified: 16 Aug 2023, 11:22 a.m.
Panel Version: 0.179
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Phenotypes
Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (MIM#616437)
Publications
Gene: sqstm1 has been classified as Amber List (Moderate Evidence).
Gene: sqstm1 has been classified as Amber List (Moderate Evidence).
Gene: sqstm1 has been classified as Amber List (Moderate Evidence).
Publications for gene: SQSTM1 were set to 22084127; 22972638
Gene: sqstm1 has been classified as Green List (High Evidence).
Gene: sqstm1 has been classified as Amber List (Moderate Evidence).
Phenotypes for gene: SQSTM1 were changed from to Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (MIM#616437)
Publications for gene: SQSTM1 were set to
Mode of inheritance for gene: SQSTM1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Gene: sqstm1 has been classified as Amber List (Moderate Evidence).
gene: SQSTM1 was added gene: SQSTM1 was added to Early-onset Dementia_MGHA_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Complex Neurology Flagship Mode of inheritance for gene: SQSTM1 was set to Unknown